Skip to content
Home/Companies/Pharma/ALIZÉ Pharma SAS

ALIZÉ Pharma SAS

Pharma·France·Exited 2017·Held 3yr
Entry
2014
Hold
3yr
Exit
2017

Who owns ALIZÉ Pharma SAS?

ALIZÉ Pharma SAS is a French Pharma company, now owned by Millendo Therapeutics, which acquired it in 2017 from Turenne Groupe.

Hand-verified · updated 2026-09-30

Open JSON · CC-BY
Turenne Groupe
Investor
Turenne Groupe
Capital Santé 2 · 2020 · Growth

Key facts

HQFrance
SectorPharma
Exit Type
Trade Sale
Buyer
Millendo Therapeutics
Exit Year
2017

More from Capital Santé 2

Other portfolio companies in the same fund.

Le Petit Souk
Active
ConsumerFrance· 2026
M&C3i
Active
SoftwareFrance· 2026
Agrotech
Active
ConstructionFrance· 2025
Anothercorp.
Active
ConsumerFrance· 2025
Groupe Colibri – Promesse de Fleurs
Active
ConsumerFrance· 2025
Kimialys
Active
IndustrialsFrance· 2025

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns ALIZÉ Pharma SAS?

ALIZÉ Pharma SAS is now owned by Millendo Therapeutics, which acquired it in 2017 from Turenne Groupe.

When did Millendo Therapeutics acquire ALIZÉ Pharma SAS?

Millendo Therapeutics acquired ALIZÉ Pharma SAS in 2017, buying from Turenne Groupe.

Who did ALIZÉ Pharma SAS sell to?

Turenne Groupe sold ALIZÉ Pharma SAS to Millendo Therapeutics in 2017 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue